Jobless Claims, Fed Yield-Curve Debate, ECB Decision: Eco Day
(Bloomberg) -- Good morning Americas. Here's the latest news and analysis from Bloomberg Economics to help get your Thursday started:
- The U.S. Labor Department's weekly jobless claims report has yet to reflect at least half a million filings for a federal pandemic program, with data reporting lagging behind payouts
- Unemployment in the U.S. is getting to the levels of the Great Depression of the 1930s, but as bad as it is, the jobless rate is a bit of an outlier. Other measures of the health of the economy are considerably stronger than they were during the Depression
- The European Central Bank is set to decide today whether even bolder rescue action is needed
- That comes after Germany has agreed on a $146 billion package to help revive the continent's biggest economy
- The Federal Reserve has a decision looming next week, although officials are unlikely to signal any new moves. Still many economists expect they will turn to yield-curve control later this year, recruiting a tool not used in the U.S. since World War II
- The economics profession has had a hard time getting a fix on racial discrimination, Peter Coy writes in Businessweek
- Coronavirus has posed a fundamental question for Americans: How will we take care of each other, now and in the future?
- Bloomberg Economics' global GDP tracker shows output continued to fall in May, albeit at a slower pace than in April
- Canada's labor market is showing clear signs of healing as lockdowns begin to lift in an economy awash in money from government support programs
- Britain's dominant services industry is being left out of the country's post-Brexit trade negotiations, putting a large part of the economy at risk of profound damage, according to a report by the U.K. in a Changing Europe
- Japan's already mammoth spending, including trillions of dollars in stimulus, likely requires a third extra budget to help plug a gaping hole spending and tax receipts
- Finally, don't miss this week's episode of the Stephanomics podcast
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
